Molecule Details
| InChIKey | YFHRCLAKZBDRHN-MRXNPFEDSA-N |
|---|---|
| Canonical SMILES | CC(C)(NC(=O)O[C@@H]1CN2CCC1CC2)c1csc(-c2ccc(F)cc2)n1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.01 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB14966 |
|---|---|
| Drug Name | Venglustat |
| CAS Number | 1401090-53-6 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Venglustat is under investigation in clinical trial NCT01674036 (Safety, Tolerability and Pharmacokinetics of Genz-682452 in Healthy Men). |
Categories: Acids, Acyclic Enzyme Inhibitors
Cross-references: BindingDB: 50593123 CHEMBL4297611 ChemSpider: 34989426 PDB: KYF ZINC: ZINC000202143443
Target Activities (2)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| Q16739 | UGCG | Ceramide glucosyltransferase | inhibitor | targets |